Showing 99,341 - 99,360 results of 101,239 for search '(( 12 men decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.74s Refine Results
  1. 99341

    Table_1_Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection.xlsx by Amélie Guihot (221393)

    Published 2022
    “…In the lung samples from 3 (1 non-ICU and 2 ICU) additional deceased cases, a lymphocytic memory CD4 T-cell angiopathy colocalizing with SARS-CoV-2 was also observed. …”
  2. 99342

    Transcriptome comparison of <i>C. glutamicum</i> ATCC 13032 cultivated in CGXII minimal medium supplemented with 21.25 µM CuSO<sub>4</sub> (Cu<sup>↑</sup>) and in standard CGXII me... by Stephanie Schelder (213218)

    Published 2011
    “…The table includes those genes which showed an at least threefold changed mRNA level (increased or decreased) in at least two of the four replicates with a <i>P</i>-value of ≤0.05.…”
  3. 99343

    Immunoglobulins and non-categorized immune genes exhibiting differential expression between resistant and susceptible birds. by Sarah Connell (147307)

    Published 2012
    “…Additionally the IgM (X01613.1), IgA (S40610.1) and IgY (X07174.1) heavy chain transcripts have significantly higher expression, indicating increased IgM, IgA and IgY production. …”
  4. 99344

    Effects of Lysophospholipid and Lipase Enzyme Supplementation to Low Metabolizable Energy Diets on Growth Performance, Intestinal Morphology and Microbial Population and Some Blood... by M Movagharnejad (10447205)

    Published 2021
    “…Two hundreds broiler chicks were assigned to a completely randomized design with five treatments and four replications with ten one-day old chicks. …”
  5. 99345
  6. 99346
  7. 99347

    Treatment with activated carbon and other adsorbents as an effective method for the removal of volatile compounds in agricultural distillates by Maria Balcerek (3683623)

    Published 2017
    “…The lowest concentrations of these congeners (expressed in mg l<sup>−1</sup> alcohol 100% v/v) were measured in solutions with ethanol contents of 70–80% v/v, while solutions with an alcoholic strength by volume of 40% did not show statistically significant decreases in these compounds in relation the control sample. …”
  8. 99348

    Histograms for comparison between the QA group and the control group. by Qiqi Feng (535984)

    Published 2014
    “…<p>Histogram A was based on the statistical analyses of brain sections with Nissl staining as well as NeuN and Darpp32 immunolabeling. …”
  9. 99349

    Prophylactic and therapeutic potential of selected immunomodulatory agents from Ayurveda against coronaviruses amidst the current formidable scenario: an <i>in silico</i> analysis by Anchal Trivedi (9743744)

    Published 2021
    “…Towards SARS-CoV-2 main and papain-like proteases, the affinity decreased as isomeldenin > EGCG > tinosporaside and EGCG > tinosporaside > isomeldenin, respectively. …”
  10. 99350
  11. 99351
  12. 99352
  13. 99353
  14. 99354

    Image_1_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”
  15. 99355

    Image_2_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”
  16. 99356
  17. 99357

    Image_3_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”
  18. 99358

    miR-22 directly targets <i>MECOM</i> mRNA to regulate monocyte/macrophage differentiation. by Chao Shen (520343)

    Published 2016
    “…The arrows pointed differentiated monocytes/macrophages. A statistical analysis for counting differentiated monocyte/macrophages in five fields is presented in the right. …”
  19. 99359

    Image_4_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”
  20. 99360

    Image_6_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”